T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The study found that 62% of study participants with sleep apnea who received peer support used the CPAP machine correctly and consistently, compared with 51% of those who only received educational ...
The study found that 62% of study participants with sleep apnea who received peer support used the CPAP machine correctly and consistently, compared with 51% of those who only received educational ...
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
Dropping 10-15% can reduce sleep apnea severity by about 50%. Aim for conventional exercise to support weight loss—or more targeted activity. Speech pathologists can lead you through exercises ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” Dr. Sally Seymour ...
If you have sleep apnea and obesity, Zepbound may offer relief and support weight loss. Ask your doctor if it’s a good fit for your treatment plan.